{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T12:27:42Z","timestamp":1791030462358,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.jns.2009.09.013","type":"journal-article","created":{"date-parts":[[2009,10,5]],"date-time":"2009-10-05T11:52:52Z","timestamp":1254743572000},"page":"41-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Low levels of plasma soluble receptor for advanced glycation end products are associated with severe leukoaraiosis in acute stroke patients"],"prefix":"10.1016","volume":"287","author":[{"given":"Chiaki","family":"Yokota","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Minematsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Tomii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Naganuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hikaru","family":"Nagasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takenori","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2009.09.013_bib1","doi-asserted-by":"crossref","first-page":"131","DOI":"10.33549\/physiolres.930430","article-title":"Advanced glycation end-products and the progress of diabetic vascular complications","volume":"53","author":"Jakus","year":"2004","journal-title":"Physiol Res"},{"key":"10.1016\/j.jns.2009.09.013_bib2","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.cardiores.2004.05.001","article-title":"Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes","volume":"63","author":"Basta","year":"2004","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jns.2009.09.013_bib3","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.2337\/diacare.24.9.1620","article-title":"Advanced glycation end products in nondiabetic patients with coronary artery disease","volume":"24","author":"Kanauchi","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jns.2009.09.013_bib4","first-page":"1061","article-title":"Relationship between the -374T\/A RAGE gene polymorphism and angiographic coronary artery disease","volume":"14","author":"Falcone","year":"2004","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.jns.2009.09.013_bib5","doi-asserted-by":"crossref","first-page":"14987","DOI":"10.1016\/S0021-9258(18)42137-0","article-title":"Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface","volume":"25","author":"Schmidt","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jns.2009.09.013_bib6","doi-asserted-by":"crossref","first-page":"14998","DOI":"10.1016\/S0021-9258(18)42138-2","article-title":"Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins","volume":"25","author":"Neeper","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jns.2009.09.013_bib7","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1161\/01.CIR.0000086014.80477.0D","article-title":"The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control","volume":"108","author":"Cipollone","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jns.2009.09.013_bib8","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1161\/01.RES.84.5.489","article-title":"Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis","volume":"84","author":"Schmidt","year":"1999","journal-title":"Circ Res"},{"key":"10.1016\/j.jns.2009.09.013_bib9","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/S0169-409X(02)00160-6","article-title":"Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings","volume":"54","author":"Stern","year":"2002","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.jns.2009.09.013_bib10","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0169-328X(99)00174-6","article-title":"cDNA cloning of a novel secreted isoform of the human receptor for advanced glycation end products and characterization of cells co-expressing cell-surface scavenger receptors and Swedish mutant amyloid precursor protein","volume":"71","author":"Malherbe","year":"1999","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.jns.2009.09.013_bib11","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1042\/bj20021371","article-title":"Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury","volume":"370","author":"Yonekura","year":"2003","journal-title":"Biochem J"},{"key":"10.1016\/j.jns.2009.09.013_bib12","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1161\/01.ATV.0000160342.20342.00","article-title":"Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men","volume":"25","author":"Falcone","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jns.2009.09.013_bib13","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jns.2008.10.002","article-title":"Albuminuria, but not metabolic syndrome, is a significant predictor of stroke recurrence in ischemic stroke","volume":"277","author":"Yokota","year":"2009","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jns.2009.09.013_bib14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000079258","article-title":"Long-term prognosis, by stroke subtypes, after a first ever stroke: a hospital-based study over a 20-year period","volume":"18","author":"Yokota","year":"2004","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.jns.2009.09.013_bib15","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","article-title":"On behalf of the collaboraters for developing Japanese equation for estimating GFR. Revised equations for estimated GFR from serum creatinine in Japan","volume":"53","author":"Matsuo","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jns.2009.09.013_bib16","doi-asserted-by":"crossref","unstructured":"Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Final report. Circulation 2002;106:3143-421.","DOI":"10.1161\/circ.106.25.3143"},{"key":"10.1016\/j.jns.2009.09.013_bib17","first-page":"199","article-title":"Metabolic syndrome-definition and diagnostic criteria in Japan","volume":"94","author":"Matsuzawa","year":"2005","journal-title":"J Jpn Soc Int Med"},{"key":"10.1016\/j.jns.2009.09.013_bib18","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1212\/WNL.43.9.1683","article-title":"Pathologic correlates of incidental MRI white matter signal hyperintensities","volume":"43","author":"Fazekas","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2009.09.013_bib19","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1096\/fj.04-1899com","article-title":"Antagonism of RAGE suppresses peripheral nerve regeneration","volume":"18","author":"Rong","year":"2004","journal-title":"FASEB J"},{"key":"10.1016\/j.jns.2009.09.013_bib20","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1096\/fj.04-1900com","article-title":"RAGE modulates peripheral nerve regeneration via recruitment of both inflammatory and axonal outgrowth pathways","volume":"18","author":"Rong","year":"2004","journal-title":"FASEB J"},{"key":"10.1016\/j.jns.2009.09.013_bib21","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/382685a0","article-title":"RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease","volume":"382","author":"Yan","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.jns.2009.09.013_bib22","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1001\/archneur.62.11.1734","article-title":"Circulating levels of soluble receptor for advanced glycation end products in Alzheimer disease and vascular dementia","volume":"62","author":"Emanuele","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jns.2009.09.013_bib23","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1097\/01.hjh.0000177535.45785.64","article-title":"Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension","volume":"23","author":"Geroldi","year":"2005","journal-title":"J Hypertens"},{"key":"10.1016\/j.jns.2009.09.013_bib24","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1161\/STROKEAHA.107.505354","article-title":"Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers","volume":"39","author":"Montaner","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2009.09.013_bib25","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.2337\/diabetes.53.10.2662","article-title":"Thiazolidinediones reduce endothelial expression of receptors for advanced glycation end products","volume":"53","author":"Marx","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.jns.2009.09.013_bib26","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1007\/s00125-006-0437-7","article-title":"Telmisartan inhibits age-induced c-reactive protein production through downregulation of the receptor for age via peroxisome proliferator-activated receptor-gamma activation","volume":"49","author":"Yoshida","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.jns.2009.09.013_bib27","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1007\/s00125-008-1060-6","article-title":"The HMG-CoA reductase inhibitor rosuvastatin and the angiotensin receptor antagonist candesartan attenuate atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes via effects on advanced glycation, oxidative stress and inflammation","volume":"51","author":"Calkin","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.jns.2009.09.013_bib28","doi-asserted-by":"crossref","first-page":"13915","DOI":"10.1073\/pnas.94.25.13915","article-title":"Tobacco smoke is a source of toxic reactive glycation products","volume":"94","author":"Cerami","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jns.2009.09.013_bib29","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/2012","article-title":"Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts","volume":"4","author":"Park","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.jns.2009.09.013_bib30","doi-asserted-by":"crossref","first-page":"25781","DOI":"10.1074\/jbc.M001235200","article-title":"The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-alpha through nuclear factor-kappa B, and by 17beta-estradiol through SP-1 in human vascular endothelial cells","volume":"275","author":"Tanaka","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jns.2009.09.013_bib31","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1053\/j.ajkd.2005.12.028","article-title":"Soluble receptor for advanced glycation end products in patients with decreased renal function","volume":"47","author":"Kalousova","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jns.2009.09.013_bib32","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000098811","article-title":"Pregnancy-associated plasma protein a and soluble receptor for advanced glycation end products after kidney transplantation","volume":"30","author":"Kalousova","year":"2007","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.jns.2009.09.013_bib33","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1096\/fj.08-109033","article-title":"A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10)","volume":"22","author":"Raucci","year":"2008","journal-title":"FASEB J"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X09008557?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X09008557?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:40:17Z","timestamp":1758382817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X09008557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":33,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S0022510X09008557"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2009.09.013","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low levels of plasma soluble receptor for advanced glycation end products are associated with severe leukoaraiosis in acute stroke patients","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2009.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}